Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
CONCLUSION: In this cohort, racial disparities may be due to higher medical comorbidities and lower rates of optimal surgical cytoreduction. After accounting for these differences, race remained an independent predictor of worse overall survival.
PMID: 29605050 [PubMed - in process]
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Dilley S, Erickson BK, Phillips CE, Kennemer CR, Zhang B, Matin T, Martin JY, Shah MS, Michael Straughn J, Leath CA Tags: Gynecol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | Ovarian Cancer | Ovaries | Study | Women